• Institution: LOCKSS
LOCKSS

Development of Potential Pharmacodynamic and Diagnostic Markers for Anti-IFN-α Monoclonal Antibody Trials in Systemic Lupus Erythematosus

Click on image to view larger version.

Table 3Table 3

This Article

  1. Hum Genomics Proteomics vol. 1 no. 1